Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06415461 · ClinicalTrials.gov registry record · Phase 1

A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)

A Phase 1 study of Pain, Back and Sacroiliac; Backache, sponsored by University of Florida.

Active
Registry status
Phase 1
Development phase
9
Enrollment target
1
Study location

NCT06415461 is a Phase 1 study of Pain, Back and Sacroiliac; Backache that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 9 participants, below the 331-participant average among 7 other Pain, Back trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06415461, a Phase 1 study of Pain, Back and Sacroiliac; Backache, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This is a Phase 1 trial. The overall objective is to evaluate the safety and potential efficacy effect of specific type of umbilical cord blood product (CFL001), which, other than specific modifications in manufacturing to render it compatible with current Good Manufacturing Practice (cGMP), is essentially similar to that reported in real-world experience.

Interventions

  • BIOLOGICAL PremierMaxCB®-Platinum (CFL001);

Study Locations (1)

Florida

  • University of Florida Pain Clinic - Gainesville

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2024-05-10
Est. Completion 2028-03-06
Phase Phase 1

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT06415461

The ClinicalTrials.gov registry entry for NCT06415461 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 7 other Pain, Back trials with a reported enrollment target (97% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Back appearing as the primary indexed condition, and to 1 intervention - of which PremierMaxCB®-Platinum (CFL001); is the first listed.

NCT06415461 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06415461 about?

NCT06415461 is a clinical study titled "A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)". This is a Phase 1 trial. The overall objective is to evaluate the safety and potential efficacy effect of specific type of umbilical cord blood product (CFL001), which, other than specific modifications in manufacturing to render it compatible with current Good Manufacturing Practice (cGMP), is esse...

What is the current status of trial NCT06415461?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2024-05-10. Estimated completion is 2028-03-06.

What conditions does trial NCT06415461 study?

This clinical trial studies the following conditions: Pain, Back, Sacroiliac; Backache.

What interventions are being tested in trial NCT06415461?

The interventions under investigation include: PremierMaxCB®-Platinum (CFL001); (BIOLOGICAL).

Who is sponsoring clinical trial NCT06415461?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06415461 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Back

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.